Literature DB >> 24277282

Skin structure and metabolism: relevance to the design of cutaneous therapeutics.

D A Bucks1.   

Abstract

The outer layer of the epidermis or stratum corneum is the major barrier to percutaneous absorption. It has been shown that there are numerous enzyme systems beneath the stratum corneum in the viable epidermis capable of metabolizing drugs. A number of prodrug and soft drug topical therapeutic agents have been designed. After these agents penetrate the stratum corneum, they are metabolized by the cutaneous esterase systems to the desired metabolites.

Year:  1984        PMID: 24277282     DOI: 10.1023/A:1016340423079

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

1.  Dermatopharmacology of salicylic acid. III. Topical contra-inflammatory effect of salicylic acid and other drugs in animal experiments.

Authors:  E G Weirich; J K Longauer; A H Kirkwood
Journal:  Dermatologica       Date:  1976

2.  [Pharmacological studies on butyl 6alpha-fluoro-11beta-hydroxy-16alpha-methyl-3,20-dioxo-1,4-pregnadien-21-oate (fluocortin butylester) (author's transl)].

Authors:  J F Kapp; H Koch; M Töpert; H J Kessler; E Gerhards
Journal:  Arzneimittelforschung       Date:  1977

3.  Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate I: Physical model development.

Authors:  C D Yu; J L Fox; N F Ho; W I Higuchi
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

4.  A multisample apparatus for kinetic evaluation of skin penetration in vitro: the influence of viability and metabolic status of the skin.

Authors:  J M Holland; J Y Kao; M J Whitaker
Journal:  Toxicol Appl Pharmacol       Date:  1984-02       Impact factor: 4.219

Review 5.  Cyclic nucleotide metabolism in normal and proliferating epidermis.

Authors:  J J Voorhees; E A Duell; M Stawiski; E R Harrell
Journal:  Adv Cyclic Nucleotide Res       Date:  1974

6.  Regional variation in percutaneous penetration of 14C cortisol in man.

Authors:  R J Feldmann; H I Maibach
Journal:  J Invest Dermatol       Date:  1967-02       Impact factor: 8.551

7.  Cytochrome P-450 content and mixed-function oxidase activity in microsomes isolated from mouse skin.

Authors:  R J Pohl; R M Philpot; J R Fouts
Journal:  Drug Metab Dispos       Date:  1976 Sep-Oct       Impact factor: 3.922

8.  Improved delivery through biological membranes XD: Percutaneous absorption and metabolism of methylsulfinylmethyl 2-acetoxybenzoate and related aspirin prodrugs.

Authors:  T Loftsson; N Bodor
Journal:  J Pharm Sci       Date:  1981-07       Impact factor: 3.534

9.  Treatment of atopic eczema in children: clinical trial of 10% sodium cromoglycate ointment.

Authors:  S A Haider
Journal:  Br Med J       Date:  1977-06-18

10.  Prodrugs of 6-thiopurines: enhanced delivery through the skin.

Authors:  K B Sloan; M Hashida; J Alexander; N Bodor; T Higuchi
Journal:  J Pharm Sci       Date:  1983-04       Impact factor: 3.534

View more
  9 in total

Review 1.  Prodrugs for the improvement of drug absorption via different routes of administration.

Authors:  L P Balant; E Doelker; P Buri
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

2.  Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris.

Authors:  H C Korting; H Zienicke; M Schäfer-Korting; O Braun-Falco
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  The bioavailability of dermatological and other topically administered drugs.

Authors:  R H Guy; A H Guy; H I Maibach; V P Shah
Journal:  Pharm Res       Date:  1986-10       Impact factor: 4.200

4.  Transdermal bioavailability and first-pass skin metabolism: a preliminary evaluation with nitroglycerin.

Authors:  E Nakashima; P K Noonan; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1987-08

5.  Transdermal drug transport and metabolism. I. Comparison of in vitro and in vivo results.

Authors:  D B Guzek; A H Kennedy; S C McNeill; E Wakshull; R O Potts
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

Review 6.  Pharmacokinetic considerations in the use of newer transdermal formulations.

Authors:  G Ridout; G C Santus; R H Guy
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

7.  Cutaneous metabolism of nitroglycerin in vitro. I. Homogenized versus intact skin.

Authors:  N Higo; R S Hinz; D T Lau; L Z Benet; R H Guy
Journal:  Pharm Res       Date:  1992-02       Impact factor: 4.200

8.  Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.

Authors:  H Arima; H Adachi; T Irie; K Uekama; J Pitha
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

9.  Biotransformation of estradiol in the human keratinocyte cell line HaCaT: metabolism kinetics and the inhibitory effect of ethanol.

Authors:  R Altenburger; T Kissel
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.